» Articles » PMID: 19380584

Membrane Repair Defects in Muscular Dystrophy Are Linked to Altered Interaction Between MG53, Caveolin-3, and Dysferlin

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2009 Apr 22
PMID 19380584
Citations 163
Authors
Affiliations
Soon will be listed here.
Abstract

Defective membrane repair can contribute to the progression of muscular dystrophy. Although mutations in caveolin-3 (Cav3) and dysferlin are linked to muscular dystrophy in human patients, the molecular mechanism underlying the functional interplay between Cav3 and dysferlin in membrane repair of muscle physiology and disease has not been fully resolved. We recently discovered that mitsugumin 53 (MG53), a muscle-specific TRIM (Tri-partite motif) family protein (TRIM72), contributes to intracellular vesicle trafficking and is an essential component of the membrane repair machinery in striated muscle. Here we show that MG53 interacts with dysferlin and Cav3 to regulate membrane repair in skeletal muscle. MG53 mediates active trafficking of intracellular vesicles to the sarcolemma and is required for movement of dysferlin to sites of cell injury during repair patch formation. Mutations in Cav3 (P104L, R26Q) that cause retention of Cav3 in Golgi apparatus result in aberrant localization of MG53 and dysferlin in a dominant-negative fashion, leading to defective membrane repair. Our data reveal that a molecular complex formed by MG53, dysferlin, and Cav3 is essential for repair of muscle membrane damage and also provide a therapeutic target for treatment of muscular and cardiovascular diseases that are linked to compromised membrane repair.

Citing Articles

Caveolin and oxidative stress in cardiac pathology.

Zadorozny L, Du J, Supanekar N, Annamalai K, Yu Q, Wang M Front Physiol. 2025; 16:1550647.

PMID: 40041164 PMC: 11876135. DOI: 10.3389/fphys.2025.1550647.


Analysis of Body Fluid Distribution, Phase Angle and Its Association With Maximal Oxygen Consumption in Facioscapulohumeral Dystrophy: An Observational Study.

Crisafulli O, Baptista R, Drid P, Grattarola L, Bottoni G, Lavaselli E Health Sci Rep. 2025; 8(1):e70335.

PMID: 39807483 PMC: 11726644. DOI: 10.1002/hsr2.70335.


Fish Oil Supplement Mitigates Muscle Injury In Vivo and In Vitro: A Preliminary Report.

Russ D, Sehested C, Banford K, Weisleder N Nutrients. 2024; 16(20).

PMID: 39458505 PMC: 11510179. DOI: 10.3390/nu16203511.


Comprehensive Proteomic Analysis of Dysferlinopathy Unveiling Molecular Mechanisms and Biomarkers Linked to Pathological Progression.

Wang D, Liu X, He Q, Zheng F, Chen L, Zheng Y CNS Neurosci Ther. 2024; 30(10):e70065.

PMID: 39350328 PMC: 11442333. DOI: 10.1111/cns.70065.


Mitochondria-encoded peptide MOTS-c participates in plasma membrane repair by facilitating the translocation of TRIM72 to membrane.

Jia H, Zhou L, Chen Y, Zhang W, Qi W, Wang P Theranostics. 2024; 14(13):5001-5021.

PMID: 39267782 PMC: 11388074. DOI: 10.7150/thno.100321.


References
1.
Sunada Y, Hase A, Ohi H, Hosono T, Arata S, Higuchi S . Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity. Hum Mol Genet. 2001; 10(3):173-8. DOI: 10.1093/hmg/10.3.173. View

2.
Klinge L, Laval S, Keers S, Haldane F, Straub V, Barresi R . From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis. FASEB J. 2007; 21(8):1768-76. DOI: 10.1096/fj.06-7659com. View

3.
Galbiati F, Razani B, Lisanti M . Caveolae and caveolin-3 in muscular dystrophy. Trends Mol Med. 2001; 7(10):435-41. DOI: 10.1016/s1471-4914(01)02105-0. View

4.
Towler M, Kaufman S, Brodsky F . Membrane traffic in skeletal muscle. Traffic. 2004; 5(3):129-39. DOI: 10.1111/j.1600-0854.2003.00164.x. View

5.
MCNALLY E, de Sa Moreira E, Duggan D, Bonnemann C, Lisanti M, Lidov H . Caveolin-3 in muscular dystrophy. Hum Mol Genet. 1998; 7(5):871-7. DOI: 10.1093/hmg/7.5.871. View